Skip to main content

The Evolution of Evidence Based Clinical Medicine

  • Chapter
  • First Online:
Practical Pediatric Urology
  • 875 Accesses

Abstract

It’s over quarter-century since the working group chaired by Gordon Guyatt introduced evidence-based medicine (EBM) as a ‘new paradigm for medical practice’ and 35 years since the foundations of evidence-based medicine were established by David Sackett. EBM has transformed medical decision making and practice in the last quarter century. EBM was established to define what constitutes acceptable evidence, namely, that which is scientific rather than personal. Defined as ‘the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients’, Sackett proposed that EBM considered the best available evidence, clinical skills and the patient’s situation and expectations. The popularity and adoption of EBM has led to globally established systems to review medical evidence that include the Cochrane Collaboration, the Oxford Centre for Evidence Based Medicine an established approach to the evaluation of clinical evidence proposed in 2000, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE). However, some have challenged the reliance on EBM, suggesting that the evidence generated is overly generalisable, is limited to treatment-efficacy and does not account for other attributes and issues relating to interventions, and that it is open to exploitation. The following chapter describes the rise and development of EBM, the systems established to review medical evidence and the criticisms that have evolved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–2.

    Article  CAS  Google Scholar 

  2. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. Boston: Little Brown; 1991.

    Google Scholar 

  3. Guyatt G. Evidence-based medicine. Ann Intern Med. 1991;14(Supp 2):A-16.

    Google Scholar 

  4. Sackett D. How to read clinical journals: I. why to read them and how to start reading them critically. Can Med Assoc J. 1981;124(5):555–8.

    Google Scholar 

  5. Smith R, Rennie D. Evidence based medicine—an oral history. BMJ. 2014;348(21):g371.

    Article  Google Scholar 

  6. Zimerman A. Evidence-based medicine: a short history of a modern medical movement. American Medical Association Journal of Ethics. 2013;15(1):71–6.

    PubMed  Google Scholar 

  7. Haynes B. Advances in evidence-based information resources for clinical practice. ACP J Club. 2000;132(1):A11–4.

    CAS  PubMed  Google Scholar 

  8. Feinstein AR. Clinical Judgement. Baltimore, MD: Williams & Wilkins; 1967.

    Google Scholar 

  9. Cochrane AL. Effectiveness and efficiency: random reflections on health services. London: Nuffield Provincial Hospitals Trust; 1972.

    Google Scholar 

  10. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268(17):2420–5.

    Article  Google Scholar 

  11. Eddy DM. Practice Policies: Guidelines for Methods. JAMA. 1990;263(13):1839–41.

    Article  CAS  Google Scholar 

  12. Eddy DM. Guidelines for policy statements. JAMA. 1990;263(16):2239–43.

    Article  CAS  Google Scholar 

  13. Eddy DM. Evidence-based medicine: a unified approach. Health Aff. 2005;24(1):9–17.

    Article  Google Scholar 

  14. Sur RL, Dahm P. History of evidence-based medicine. Indian J Urol. 2011;4:487–9.

    Article  Google Scholar 

  15. Cochrane AL, Cox JG, Jarman TF. Pulmonary tuberculosis in the Rhondda Fach; an interim report of a survey of a mining community. Br Med J. 1952;2:843–53.

    Article  CAS  Google Scholar 

  16. Chalmers I, Enkin M, Keirse MJ, editors. Effective Care in Pregnancy and Childbirth. New York, NY: Oxford University Press; 1989.

    Google Scholar 

  17. Dawes M. EBM Volume 5 July/August 2000 103. https://ebm.bmj.com/content/5/4/102.

  18. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1989;95:2S–4S.

    Article  CAS  Google Scholar 

  19. OCEBM Table of Evidence Working Group: Howick J, Chalmers I (James Lind Library), Glasziou P, Greenhalgh T, Heneghan C, Liberati A, Moschetti I, Phillips B, Thornton H, Goddard O, Hodgkinson M. The Oxford 2011 levels of evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653.

  20. Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendation (Version 3.2 ed.); 2009.

    Google Scholar 

  21. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed). 2008;336(7650):924–6.

    Article  Google Scholar 

  22. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94.

    Article  Google Scholar 

  23. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2011;343:d5928.

    Article  Google Scholar 

  24. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011. Oxford. Asp; 2011

    Google Scholar 

  25. Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical research ed). 2016;355:i4919.

    PubMed  PubMed Central  Google Scholar 

  26. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to recommendations. BMJ (Clinical research ed). 2008;336(7652):1049–51.

    Article  Google Scholar 

  27. La Caze A. The role of basic science in evidence-based medicine. Biology & Philosophy. 2011;26(1):81–98.

    Article  Google Scholar 

  28. Timmermans S, Berg M. The gold standard: the challenge of evidence-based medicine and standardization in health care. Philadelphia: Temple University Press; 2003.

    Google Scholar 

  29. Feinstein AR, Massa RD. Problems of ‘evidence’ in ‘evidence-based medicine’. Am J Med. 1997;103:529–35.

    Article  CAS  Google Scholar 

  30. Fava GA, Guidi J, Rafanelli C, Sonino N. The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment. Psychother Psychosom. 2015;84(1):1–3.

    Article  Google Scholar 

  31. Richardson WS, Doster LM. Comorbidity and multimorbidity need to be placed in the context of a framework of risk, responsiveness, and vulnerability. J Clin Epidemiol. 2014;67:244–6.

    Article  Google Scholar 

  32. Berlin JA, Golub RM. Meta-analysis as evidence: building a better pyramid. JAMA. 2014;312:603–5.

    Article  CAS  Google Scholar 

  33. Dechartres A, Altman DG, Trinquart L, et al. Association between analytic strategy and estimates of treatment outcomes in meta-analyses. JAMA. 2014;312:623–30.

    Article  CAS  Google Scholar 

  34. Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med. 2016 Aug;21(4):125–7.

    Article  Google Scholar 

  35. James J. Reviving Cochrane’s contribution to evidence-based medicine: bridging the gap between evidence of efficacy and evidence of effectiveness and cost-effectiveness. Eur J Clin Investig. 2017;47(9):617–21.

    Article  Google Scholar 

  36. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.

    Article  Google Scholar 

  37. Greenhalgh T, Howick J, Maskrey N. Evidence based medicine: a movement in crisis? BMJ. 2014;348:g3725.

    Article  Google Scholar 

  38. Lavis JN, Davies HT, Gruen RL, Walshe K, Farquhar CM. Working within and beyond the Cochrane collaboration to make systematic reviews more useful to healthcare managers and policy makers. Healthcare Policy. 2006;1:21–33.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Dimitri .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dimitri, P. (2021). The Evolution of Evidence Based Clinical Medicine. In: Godbole, P., Wilcox, D.T., Koyle, M.A. (eds) Practical Pediatric Urology. Springer, Cham. https://doi.org/10.1007/978-3-030-54020-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-54020-3_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-54019-7

  • Online ISBN: 978-3-030-54020-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics